Artal Group S.A. Ironwood Pharmaceuticals Inc Transaction History

Artal Group S.A.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 09, 2018	SELL	$14.31 - $17.65 $1.52 Million - $1.88 Million	-106,347 Reduced 49.04%	110,532 $2.04 Million
Q1 2018 May 10, 2018	SELL	$11.13 - $13.63 $3.34 Million - $4.09 Million	-300,000 Reduced 58.04%	216,879 $3.35 Million
Q4 2017 Feb 09, 2018	SELL	$12.16 - $14.58 $3.65 Million - $4.37 Million	-300,000 Reduced 36.73%	516,879 $7.75 Million
Q3 2017 Nov 08, 2017	BUY	$12.07 - $14.87 $9.86 Million - $12.1 Million	816,879	816,879 $12.9 Million

235

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $568M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

Stay updated on Artal Group S.A. with notifications on news.